NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ... Use of two high-risk cardiovascular devices—the Watchman (Boston Scientific) left atrial appendage occluder and the Impella (Abiomed) left ventricular assist device—is highest in the United States ... Please provide your email address to receive an email when new articles are posted on .
Abiomed is recalling specific Impella 5.5 left ventricular device systems due to product leakage. The FDA ... Select patients with heart failure fitted with an implantable left ventricular assist device can be safely moved to a stepdown unit (SDU) from intensive care unit (ICU), reducing costs, reported ... High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump during complex PCI procedures than those provided with a microaxial flow ...
impella left ventricular assist device, Abiomed has recalled the labeling for catheters used in its Impella RP Flex with Smart Assist System, the US Food and Drug Administration announced Thursday. The action comes from concern over a lack ...
